drug pricing

The Readout Meghana Keshavan

STAT Plus: We now know Tome’s gene editing target

The Readout Meghana Keshavan

STAT Plus: The public wants Medicare to cover obesity drugs

The Readout Elaine Chen

STAT Plus: Yet another big financing round in immunology

The Readout Elaine Chen

STAT Plus: Pharma has over $500B in capital for deals

The Readout Elaine Chen

STAT Plus: Vertex starts gene therapy Casgevy in five patients 

First Opinion Jason Shafrin, Louis Garrison, and Melanie D. Whittington

The world is relying on the United States to get value-based drug pricing right

The Readout Meghana Keshavan

STAT Plus: Merck may have a competition for ever-scarce BCG

The Readout Meghana Keshavan

STAT Plus: ICER casts doubt on Sarepta’s DMD gene therapy

Politics John Wilkerson

STAT Plus: Senate drug shortage bill would pay hospitals bonuses for good contracting practices

The Readout Elaine Chen

STAT Plus: The biotech news you need to read this morning

The Readout Elaine Chen

STAT Plus: The latest government crackdowns on biotech you need to know

Pharmalot Ed Silverman

STAT Plus: FTC issues warnings on ‘junk’ patent listings for Ozempic and other drugs

The Readout Elaine Chen

STAT Plus: FDA wants to hear your thoughts on advisory committees 

Politics Rachel Cohrs Zhang

STAT Plus: Federal judge rules against two drugmakers challenging Medicare drug price negotiation program

Pharmalot Ed Silverman

STAT Plus: Vertex offers limited access to a cystic fibrosis drug in South Africa — and may undercut a court case

Pharmalot Ed Silverman

STAT Plus: Thanks to CVS, a biosimilar version of AbbVie’s Humira is grabbing huge market share

The Readout Damian Garde

STAT Plus: What about the company Vertex didn’t buy?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more

The Readout Damian Garde

STAT Plus: Gas prices are hurting biotech

Pharmalot Ed Silverman

STAT Plus: Regeneron accused by Justice Department of manipulating Medicare pricing

The Readout Meghana Keshavan

STAT Plus: AskBio CSO steps down, has new project in stealth mode

The Readout Damian Garde

STAT Plus: Pfizer’s plot to win the RSV vaccine race

The Readout Meghana Keshavan

STAT Plus: Sanofi resolves most Zantac litigation

Exclusive John Wilkerson

STAT Plus: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market

The Readout Meghana Keshavan

STAT Plus: How resurrecting extinct species might impact medicine

The Readout Meghana Keshavan

STAT Plus: New data on liquid biopsy for colorectal cancer detection still underwhelms

The Readout Meghana Keshavan

STAT Plus: Lawmakers want to add more Chinese biotechs to defense list

The Readout Damian Garde

STAT Plus: What’s Congress going to do with WuXi?

The Readout Meghana Keshavan

STAT Plus: How GLP-1’s moved from research labs to national TV